Search - tctmd.com

Displaying 561 - 580 of 1344

Sort: Relevancy | Date

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Presentation TCT Abstracts Posters 2019

Using Artificial Intelligence To Match Culprit Lesions In Acute Coronary Syndrome With Turbulent Flow Caused By Collision Of Antegrade And Retrograde Coronary Flow

Presenter: Loc Vu

September 29, 2019

Presentation TCT 2019

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Presenter: Duk-Woo Park

September 28, 2019

Challenging Case of TAVI, in AORTIC Valve Without Calcium

Presentation TCT 2019

Challenging Case of Acute Coronary Syndrome

Presenter: Carlos Cabrera Arroyo

September 27, 2019

Presentation TCT 2019

Approach to Patients With Acute Coronary Syndromes (Including SCAD) and Thrombotic Lesions Using Intravascular Imaging: Does Everyone Need a Stent?

Presenter: Tej Sheth

September 27, 2019

Presentation TCT 2019

Advance Warning of Acute Coronary Syndrome Events (AngelMed): “Getting to the Church on Time”

Presenter: David Holmes Jr

September 26, 2019

Presentation TCT 2019

Machine Learning for Risk Prediction of Future Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Presenter: Jin Sup

September 26, 2019

Presentation TCT 2019

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Presenter: Stephan Windecker

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

Presentation TCT 2019

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Presenter: Gregory Serrao

September 25, 2019

News Industry News

Angel Medical Systems Inc. Assembles World-Class Medical Advisory Board

September 20, 2019

Presentation ESC 2019

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Presenter: Johannes Neumann

September 01, 2019

News Conference News ESC 2019

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Michael O'Riordan

September 01, 2019

Presentation ESC 2019

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

Presenter: David B. Brieger

September 01, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Conference News ESC 2019

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Michael O'Riordan

August 31, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

High-Sensitivity Troponin Performs Well Against Traditional Tools for 30-Day MACE Prediction

Marcus A. Banks

August 13, 2019

Advertisement

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Using Artificial Intelligence To Match Culprit Lesions In Acute Coronary Syndrome With Turbulent Flow Caused By Collision Of Antegrade And Retrograde Coronary Flow

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Challenging Case of Acute Coronary Syndrome

Approach to Patients With Acute Coronary Syndromes (Including SCAD) and Thrombotic Lesions Using Intravascular Imaging: Does Everyone Need a Stent?

Advance Warning of Acute Coronary Syndrome Events (AngelMed): “Getting to the Church on Time”

Machine Learning for Risk Prediction of Future Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Angel Medical Systems Inc. Assembles World-Class Medical Advisory Board

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

High-Sensitivity Troponin Performs Well Against Traditional Tools for 30-Day MACE Prediction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content